Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 28, 2022; 28(28): 3739-3742
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3739
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3739
Question | Yes/No/Do not know | Score |
Are there previous conclusive reports on this reaction? | Yes | 1 |
Did the adverse event appear after the suspected drug was administered? | Yes | 2 |
Did the adverse reaction improve when the drug was discontinued, or a specific antagonist was administered? | Yes | 1 |
Are there alternative causes (other than the drug) that could on their own have caused the reaction? | No | 0 |
Was the reaction more severe when the dose was increased or less severe when the dose was decreased? | Yes | 1 |
Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | No | 0 |
Did any objective evidence confirm the adverse event? | Yes | 1 |
Were there any symptoms or signs of abdominal pathology? (instead of isolation of drug in toxic concentrations in body fluid) | No | 1 |
Were the serum inflammatory markers normal? (instead of drug rechallenge to evaluate for reoccurrence of symptoms) | Yes | 1 |
Did imaging studies rule out hollow viscus perforation or inflammatory abdominal organ pathology? (instead of response to placebo administration) | Yes | 1 |
Total score | 9 (definite) |
Total score | Interpretation of scores |
≥ 9 | Definite |
5 to 8 | Probable |
1 to 4 | Possible |
≤ 0 | Doubtful |
- Citation: Goh SSN, Shelat V. Prednisolone induced pneumatosis coli and pneumoperitoneum. World J Gastroenterol 2022; 28(28): 3739-3742
- URL: https://www.wjgnet.com/1007-9327/full/v28/i28/3739.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i28.3739